The researcher of the future...engages with industry.
The researcher of the future...engages with industry.
复制标题
DOI：
10.1016/s0140-6736(13)60448-1
复制
发表时间：
2013-02-27
期刊：
影响因子：
--
通讯作者：
Fallowfield, Jonathan
中科院分区：
文献类型：
--
作者：
Fallowfield, Jonathan
Innovation and collaboration are now regarded as crucial for the future success of industry, efficiency of the National Health Service, improved outcomes for patients, and catalysing economic growth in the UK. The scientific landscape has changed dramatically in recent years. Big pharma is increasingly outsourcing research and development to boost pipelines as drug development budgets contract, and universities are transforming from ivory towers to engines of economic growth. Academia needs industry. Industry needs academia. 1 Consequently, there are great and varied opportunities for the more proactive, entrepreneurial researcher to exploit. My personal experience of engaging with industry has had both highs and lows and reflects the complex nature of academic researchers’ interactions with biotechnology and pharmaceutical organisations. Like most academics, research-related factors (rather than commercialisation) have been my primary motivators for engagement. 2Industry engagement often generates considerable benefits for academic research, including funding, in-kind resources (eg, high throughput facilities, small molecule libraries), commercial exploitation of technology or intellectual property, and cross-fertilisation of knowledge and skills. Accordingly, interactions between academics and industry can take multiple forms, 1 such as collaborative (precompetitive) research often subsidised by public funding, contract research directly commissioned by companies, and consultancy services provided by individual academic researchers to industry. It is important to recognise that the different objectives and ethos of academia and industry can potentially cause conflict. Whereas researchers may be concerned with restrictions to academic freedom and the right to publish, industry may be more focused on protection of confidential information and intellectual property, market penetration, and shareholder value. Likewise, the entrepreneurial university will also seek commercially relevant outputs such as patents and spin-offs. 1 The Lambert review of business-university collaboration made a series of recommendations aimed at smoothing out the path between the UK’s strong science base and the business community. 3 Responses to the report suggest that it should be possible to reconcile the often divergent interests of both parties through intelligent
